We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+5.72%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.71B
AUM Growth
-$44.3M
Cap. Flow
-$66.1M
Cap. Flow %
-2.44%
Top 10 Hldgs %
17.98%
Holding
299
New
64
Increased
62
Reduced
142
Closed
18

Top Buys

Rank Stock Value
1
HRI icon
Herc Holdings
HRI
+$20.6M
2
CUBI icon
Customers Bancorp
CUBI
+$17.9M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$14.4M
4
HRT
HireRight Holdings Corporation
HRT
+$13.4M
5
RIOT icon
Riot Platforms
RIOT
+$10.7M

Top Sells

Rank Stock Value
1
CHGG icon
Chegg
CHGG
+$22.7M
2
TREX icon
Trex
TREX
+$17.5M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$15.4M
4
TTEK icon
Tetra Tech
TTEK
+$15.3M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$15.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 17.94%
3 Consumer Discretionary 17%
4 Industrials 15.63%
5 Financials 14.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMD icon
276
Advanced Micro Devices
AMD
$821B
– –
-2,885
Closed -$297K
AVIR icon
277
Atea Pharmaceuticals
AVIR
$383M
– –
-173,950
Closed -$6.1M
C icon
278
Citigroup
C
$216B
$0 ﹤0.01%
+6
New +$399
CHWY icon
279
Chewy
CHWY
$9B
– –
-5,015
Closed -$342K
CTLP
280
DELISTED
Cantaloupe
CTLP
– –
-16,190
Closed -$175K
FATE icon
281
Fate Therapeutics
FATE
$325M
– –
-176,956
Closed -$10.5M
IONS icon
282
Ionis Pharmaceuticals
IONS
$8.75B
– –
-16,815
Closed -$564K
KALV
283
DELISTED
KalVista Pharmaceuticals
KALV
– –
-304,113
Closed -$5.31M
MRVI icon
284
Maravai LifeSciences
MRVI
$1.03B
– –
-7,382
Closed -$362K
OLPX
285
DELISTED
Olaplex Holdings
OLPX
– –
-28,560
Closed -$700K
ORIC icon
286
Oric Pharmaceuticals
ORIC
$1.08B
– –
-726,236
Closed -$15.2M
PASG icon
287
Passage Bio
PASG
$15.5M
– –
-7,035
Closed -$1.4M
TGTX icon
288
TG Therapeutics
TGTX
$8.26B
– –
-8,941
Closed -$298K
CPAY icon
289
Corpay
CPAY
$24.1B
– –
-2,118
Closed -$553K
CTLT
290
DELISTED
CATALENT, INC.
CTLT
– –
-8,540
Closed -$1.14M
STER
291
DELISTED
Sterling Check Corp. Common Stock
STER
– –
-411,880
Closed -$10.7M
SPLK
292
DELISTED
Splunk Inc
SPLK
– –
-3,099
Closed -$448K
TPTX
293
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
– –
-115,983
Closed -$7.71M
ECHO
294
DELISTED
Echo Global Logistics, Inc.
ECHO
– –
-244,790
Closed -$11.7M
QTWW
295
DELISTED
QUANTUM FUEL SYS TECHNOLOGIES WORLDWIDE INC COM STK (DE)
QTWW
$0 ﹤0.01%
+15
New –
8 9 10 11
12

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, Emerald Advisers held 299 positions worth $2.71B, down 1.6% from $2.75B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Advisers's Q4 2021 filing shows 64 new, 62 increased, 142 reduced and 18 closed positions. Its largest new stake was Herc Holdings: 116,724 shares worth $18.3M. The largest sale was Chegg, an estimated $22.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Emerald Advisers's largest Q4 2021 buy was Herc Holdings: 116,724 shares worth $18.3M.
  • Emerald Advisers added most to Customers Bancorp in Q4 2021, an estimated $17.9M increase.
  • Emerald Advisers's biggest Q4 2021 reduction was Chegg, cutting an estimated $22.7M.
  • Emerald Advisers fully exited Oric Pharmaceuticals in Q4 2021, selling an estimated $15.2M.
  • Emerald Advisers's ten largest holdings make up 18% of its $2.71B portfolio in Q4 2021.
  • Emerald Advisers opened 64 new positions and closed 18 in Q4 2021.
  • Emerald Advisers's portfolio value fell 1.6% quarter-over-quarter to $2.71B.

Based on Emerald Advisers's 13F filing for Q4 2021, filed 2 Feb 2022.